Local Injection Treatment for Lateral Epicondylitis

Altay, Taşkın; Günal, İzge; Öztürk, Haluk

doi:10.1097/00003086-200205000-00018

Cited by 127 publications

(71 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…34,35 Although a needling effect and subtendinous/intratendinous fluid infusion may contribute to the clinical benefit in this study, trauma was minimized via use of a 27-gauge needle, with 3 to 6 gentle entries through a tendon, and only light bone contact. Given identical needling technique in both dextrose and lidocaine groups in this study design, a unique quality of dextrose must account for its superior efficacy.…”

Section: Consideration Of Possible Mechanisms and Explanationsmentioning

confidence: 99%

Hyperosmolar Dextrose Injection for Recalcitrant Osgood-Schlatter Disease

Topol¹,

Podestá

Reeves

et al. 2011

Pediatrics

View full text Add to dashboard Cite

WHAT'S KNOWN ON THIS SUBJECT:Osgood-Schlatter disease symptoms may wax and wane until maturity and affect sport confidence and participation periodically. Chronic sequelae may include anterior knee pain, kneeling discomfort, or sports limitation. Symptom reduction parallels resolution of patellar tendinopathy by MRI/ultrasound, although ossicles may persist radiographically. WHAT THIS STUDY ADDS:Small-needle injection of the patellar tendon enthesis/tibial apophysis with 12.5% dextrose was safe and well tolerated in adolescents with recalcitrant OsgoodSchlatter disease. Dextrose injection resulted in more rapid and frequent achievement of unaltered sport and asymptomatic sport than did usual care. abstract OBJECTIVE: To examine the potential of dextrose injection versus lidocaine injection versus supervised usual care to reduce sport alteration and sport-related symptoms in adolescent athletes with OsgoodSchlatter disease. PATIENTS AND METHODS: Girls aged 9 to 15 and boys aged 10 to 17 were randomly assigned to either therapist-supervised usual care or double-blind injection of 1% lidocaine solution with or without 12.5% dextrose. Injections were administered monthly for 3 months. All subjects were then offered dextrose injections monthly as needed. Unaltered sport (Nirschl Pain Phase Scale Ͻ 4) and asymptomatic sport (Nirschl Pain Phase Scale ϭ 0) were the threshold goals. RESULTS: Sixty-five knees in 54 athletes were treated. Compared with usual care at 3 months, unaltered sport was more common in both dextrose-treated (21 of 21 vs 13 of 22; P ϭ .001) and lidocaine-treated (20 of 22 vs 13 of 22; P ϭ .034) knees, and asymptomatic sport was more frequent in dextrose-treated knees than either lidocaine-treated (14 of 21 vs 5 of 22; P ϭ .006) or usual-care-treated (14 of 21 vs 3 of 22; P Ͻ .001) knees. At 1 year, asymptomatic sport was more common in dextrose-treated knees than knees treated with only lidocaine (32 of 38 vs 6 of 13; P ϭ .024) or only usual care (32 of 38 vs 2 of 14; P Ͻ .0001). CONCLUSIONS: Our results suggest superior symptom-reduction efficacy of injection therapy over usual care in the treatment of OsgoodSchlatter disease in adolescents. A significant component of the effect seems to be associated with the dextrose component of a dextrose/ lidocaine solution. Dextrose injection over the apophysis and patellar tendon origin was safe and well tolerated and resulted in more rapid and frequent achievement of unaltered sport and asymptomatic sport than usual care. Pediatrics 2011;128:e1121-e1128

show abstract

Section: Consideration Of Possible Mechanisms and Explanationsmentioning

confidence: 99%

Hyperosmolar Dextrose Injection for Recalcitrant Osgood-Schlatter Disease

Topol¹,

Podestá

Reeves

et al. 2011

Pediatrics

View full text Add to dashboard Cite

show abstract

“…Physical therapy, though, is also used in our study in the post procedure stretching and strengthening exercises. Corticosteroid injections have been used most popularly and extensively for treatment, but studies have raised certain doubts about their efficacy 15,16 . Superficial injection of corticosteroid injections may result in subcutaneous atrophy and sometimes leading to permanent ultra structural changes following intratendinous injection, as observed by Jobe and Ciccotti 17 .…”

Section: Discussionmentioning

confidence: 99%

Treatment of Refractory Lateral Epicondylitis of Humerus with Local Autologous Plasma Injection

Roy¹,

Mondal²

2017

IOSR JDMS

View full text Add to dashboard Cite

show abstract

“…[16][17][18][19] Adverse reactions include skin depigmentation and decrease in tenocyte replication and collagen production. 20 Another serious adverse effect include rupture of common extensor tendon.…”

Section: Local Steroid Injectionmentioning

confidence: 99%

Autologous blood injection technique in the treatment of refractory lateral elbow tendinopathy

2017

View full text Add to dashboard Cite

Background: Lateral elbow tendinopathy is a very common clinical condition whose management by the consultant often shifts from one to another modality. This study was conducted to know the efficacy of a minimally invasive technique of autologous blood injection in patients who were resistant to more conservative methods.Methods: This is a randomized prospective study of forty-eight patients (median age, 37 to 40 years), presenting with lateral elbow symptoms for a duration of more than six weeks and failed to respond to other methods of conservative treatment. Patients were consecutively grouped into treatment with autologous blood injections (Group I, n = 24) and control group with injection of normal saline (Group II, n = 24). 1 ml of autologous blood was drawn from dorsal venous arch and injected into the site of maximum tenderness over lateral aspect of the elbow under all aseptic precautions for all patients in group I. Similarly 1 ml of normal saline was injected at the site of maximum tenderness for patients in group II. Results were evaluated based on severity of the elbow complaints, tenderness and Cozen’s test at the end of follow-up of twenty weeks.Results: The incidence of this condition was more in the third decade 39.6% (n=19), with female preponderance 58.3% (n=28) and the dominant arm being more commonly involved 58.3% (n=28). Excellent results were found in group I in n=15 (62.5%) whereas poor results were more in group II in n=14 (58.3%). Group I had poor result only in n=03 (12.5%) of patients who later were given another dose of autologous blood or were treated surgically. Conclusions: Injection of autologous blood is a very efficacious minimally invasive procedure with satisfactory results in patients of lateral elbow tendinopathy who do not respond to other conservative methods of treatment.

show abstract

Local Injection Treatment for Lateral Epicondylitis

Cited by 127 publications

References 13 publications

Hyperosmolar Dextrose Injection for Recalcitrant Osgood-Schlatter Disease

Hyperosmolar Dextrose Injection for Recalcitrant Osgood-Schlatter Disease

Treatment of Refractory Lateral Epicondylitis of Humerus with Local Autologous Plasma Injection

Autologous blood injection technique in the treatment of refractory lateral elbow tendinopathy

Contact Info

Product

Resources

About